Pdt Partners, LLC Surface Oncology, Inc. Transaction History

Pdt Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.42 - $3.15 $128,412 - $284,857	-90,431 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.65 - $5.08 $36,925 - $70,784	-13,934 Reduced 13.35%	90,431 $266,000
Q4 2021 Feb 14, 2022	BUY	$4.73 - $7.9 $493,646 - $824,483	104,365 New	104,365 $499,000
Q1 2021 May 17, 2021	SELL	$7.25 - $13.82 $135,966 - $259,180	-18,754 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$5.06 - $7.23 $94,895 - $135,591	18,754 New	18,754 $129,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.